Benitec Biopharma Profit Margin

Benitec Biopharma (BNTC) currently reports a profit margin of -8792.09% as of March 2026. That is below the sector sector average of 21.34%. Use the charts on this page to explore Benitec Biopharma's profit margin history and peer comparisons.

Benitec Biopharma's profit margin of -8792.09% is lower than the its sector sector average of 21.34%. That is roughly 41296.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Benitec Biopharma's current -8792.09% should be judged against industry norms (sector average: 21.34%) and against BNTC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -8792.09%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 21.34%. From there, open related valuation or income-statement pages for Benitec Biopharma, and consider following BNTC for alerts when major investors trade the stock.